Ultrastructural Changes on Clinical Isolates of Trichophyton rubrum, Trichophyton mentagrophytes, and Microsporum gypseum Caused by Solanum chrysotrichum Saponin SC-2

Abstract

Worldwide, dermatophytoses represent a high percentage of all superficial mycoses. The most frequently isolated dermatophyte is Trichophyton rubrum. Solanum chrysotrichum is a vegetal species widely used in Mexican traditional medicine to treat skin infections; its extract has been used to formulate an herbal medicinal product that is used successfully to treat tinea pedis. Spirostanic saponin SC-2 from S. chrysotrichum possesses high activity against dermatophytes. The present study reports the ultrastructural changes observed by means of transmission electron microscopy (TEM) in clinical isolates of T. rubrum, T. mentagrophytes, and Microsporum gypseum induced by saponin SC-2. Strains were grown in RPMI 1640 containing SC-2 (1600 µg/mL). Fungi were harvested at 6, 12, 24, and 48 h; controls without SC-2 were included. T. mentagrophytes was the most susceptible to the SC-2 saponin, followed by M. gypseum, while T. rubrum was the most resistant. The main alterations caused by the SC-2 saponin were as follows: i) loss of cytoplasmic membrane continuity; ii) organelle degradation; iii) to a lesser extent, irreversible damage to the fungal wall; and iv) cellular death.

Key words

Solanum chrysotrichum - Solanaceae - spirostanic saponin - Trichophyton rubrum - Trichophyton mentagrophytes - Microsporum gypseum

References

• 1 Degreef H. Clinical forms of dermatophytoses (ringworm infection).  Mycopathologia. 2008;  166 257-265
• 2 Havlickova B, Czaika V A, Friedrich M. Epidemiological trends in skin mycoses worldwide.  Mycoses. 2008;  51 (Suppl. 4) 2-15
• 3 Arenas R. Dermatofitosis en México.  Rev Iberoam Micol. 2002;  19 63-67
• 4 Hernández-Salazar A, Carbajal-Pruneda P, Fernández Martínez R, Arenas R. Dermatofitosis por Trichophyton rubrum. Experiencia de 10 años (1996–2005) en un servicio de dermatología de un hospital general de la Ciudad de México.  Rev Iberoam Micol. 2007;  24 122-124
• 5 Herrera-Arellano A, Rodríguez-Soberanes A, Martínez-Rivera M, Martínez-Cruz E, Zamilpa A, Alvarez L, Tortoriello J. Effectiveness and tolerability of a standardized phytodrug derived from Solanum chrysotrichum on tinea pedis: a controlled and randomized clinical trial.  Planta Med. 2003;  69 1-6
• 6 Seebacher C, Bouchara J P, Mignon B. Updates on the epidemiology of dermatophyte infections.  Mycopathologia. 2008;  166 335-352
• 7 Manzano-Gayosso P, Méndez-Tovar L J, Hernández-Hernández F, López-Martínez R. La resistencia a los antifúngicos: un problema emergente en México.  Gac Med Mex. 2008;  144 23-26
• 8 Méndez-Tovar L J, Manzano-Gayosso P, Velásquez-Hernández V, Millán-Chiu B, Hernández-Hernández F, Mondragón-González R, López-Martínez R. Resistencia a compuestos azólicos de aislamientos clínicos de Trichophyton spp.  Rev Iberoam Micol. 2007;  24 320-322
• 9 Martinez-Rossi N M, Peres N T, Rossi A. Antifungal resistance mechanisms in dermatophytes.  Mycopathologia. 2008;  166 369-383
• 10 Watanabe S. Present state and future direction of topical antifungals.  Nippon Ishinkin Gakkai Zasshi. 1999;  40 151-155
• 11 Lesher J L. Oral therapy of common superficial fungal infections of the skin.  J Am Acad Dermatol. 1999;  40 S31-S34
• 12 de Pauw B E. Is there a need for new antifungal agents?.  Clin Microbiol Infect. 2000;  6 23-28
• 13 Bennett M L, Fleischer A B, Loveless J W, Feldman S R. Oral griseofulvin remains the treatment of choice for tinea capitis in children.  Pediatr Dermatol. 2000;  17 304-309
• 14 Koroishi A M, Foss S R, Cortez D A, Ueda-Nakamura T, Nakamura C V, Dias Filho B P. In vitro antifungal activity of extracts and neolignans from Piper regnellii against dermatophytes.  J Ethnopharmacol. 2008;  117 270-277
• 15 Lozoya X, Navarro V, García M, Zurita M. Solanum chrysotrichum (Schldl.) a plant used in Mexico for the treatment of skin mycosis.  J Ethnopharmacol. 1992;  36 127-132
• 16 Zamilpa A, Tortoriello J, Navarro V, Delgado G, Alvarez L. Five new steroidal saponins from Solanum chrysotrichum leaves and their antimycotic activity.  J Nat Prod. 2002;  65 1815-1819
• 17 Herrera-Arellano A, Martínez Rivera M A, Hernández Cruz M, López Villegas E O, Rodríguez Tovar A V, Alvarez Berber L, Marquina-Bahena S, Navarro-García V, Tortoriello J. Mycologic and transmission electron microscopy study of Solanum chrysotrichum saponin SC‐2 antifungal activity on Candida species of medical significance.  Planta Med. 2007;  73 1568-1573
• 18 Herrera-Arellano A, Jiménez-Ferrer E, Vega-Pimentel A M, Martínez-Rivera M, Hernández-Hernández M, Zamilpa A, Tortoriello J. Clinical and mycological evaluation of therapeutic effectiveness of Solanum chrysotrichum standardized extract on patients with pityriasis capitis (dandruff). A double blind and randomized clinical trial controlled with ketoconazole.  Planta Med. 2004;  70 483-488
• 19 Herrera-Arellano A, Jiménez-Ferrer E, Zamilpa A, Martínez-Rivera M A, Rodríguez-Tovar A V, Herrera-Alvarez S, Salas-Andonaegui M L, Nava-Xalpa M Y, Méndez-Salas A, Tortoriello J. Exploratory study on the clinical and mycological effectiveness of an herbal medicinal product from Solanum chrysotrichum in patients with Candida yeast-associated vaginal infection.  Planta Med. 2009;  75 466-471
• 20 Simons V, Morrissey J P, Latijnhouwers M, Csukai M, Cleaver A, Yarrow C, Osbourn A. Dual effects of plant steroidal alkaloids on Saccharomyces cerevisiae.  Antimicrob Agent Chemother. 2006;  50 2732-2740
• 21 Bruneton J. Pharmacognosy phytochemistry, medicinal plants, 2nd edition. Paris; Lavoisier Publishing 1999: 671-719